Polyamine and Ethanolamine Metabolism in Bacteria as an Important Component of Nitrogen Assimilation for Survival and Pathogenicity

Med Sci (Basel). 2022 Jul 29;10(3):40. doi: 10.3390/medsci10030040.

Abstract

Nitrogen is an essential element required for bacterial growth. It serves as a building block for the biosynthesis of macromolecules and provides precursors for secondary metabolites. Bacteria have developed the ability to use various nitrogen sources and possess two enzyme systems for nitrogen assimilation involving glutamine synthetase/glutamate synthase and glutamate dehydrogenase. Microorganisms living in habitats with changeable availability of nutrients have developed strategies to survive under nitrogen limitation. One adaptation is the ability to acquire nitrogen from alternative sources including the polyamines putrescine, cadaverine, spermidine and spermine, as well as the monoamine ethanolamine. Bacterial polyamine and monoamine metabolism is not only important under low nitrogen availability, but it is also required to survive under high concentrations of these compounds. Such conditions can occur in diverse habitats such as soil, plant tissues and human cells. Strategies of pathogenic and non-pathogenic bacteria to survive in the presence of poly- and monoamines offer the possibility to combat pathogens by using their capability to metabolize polyamines as an antibiotic drug target. This work aims to summarize the knowledge on poly- and monoamine metabolism in bacteria and its role in nitrogen metabolism.

Keywords: bacteria; drug discovery; ethanolamine metabolism; nitrogen assimilation; polyamine metabolism.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bacteria / metabolism
  • Ethanolamines
  • Humans
  • Nitrogen* / metabolism
  • Polyamines* / metabolism
  • Virulence

Substances

  • Ethanolamines
  • Polyamines
  • Nitrogen

Grants and funding

This work was supported by the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG)-funded Research Training Group GRK1708 (I and II) and the BMBF (Fördermaßnahme “Targetvalidierung für die pharmazeutische Wirkstoffentwicklung”) project GPS-TBT (FKZ: 16 GW0183K), as well as project GSS-TUBTAR (FKZ: 16 GW0253K). SK was a member of the DFG Research Training Group GRK1708 (I and II).